• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有系统性红斑狼疮的绝经前女性的膳食钙与骨矿物质密度

Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus.

作者信息

Chong H C, Chee S S, Goh E M L, Chow S K, Yeap S S

机构信息

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Clin Rheumatol. 2007 Feb;26(2):182-5. doi: 10.1007/s10067-006-0258-6. Epub 2006 Mar 25.

DOI:10.1007/s10067-006-0258-6
PMID:16565892
Abstract

The primary objective of this study was to determine the relationship between dietary calcium intake and bone mineral density (BMD) in premenopausal women with systemic lupus erythematosus (SLE) on corticosteroids (CS). The secondary aim was to identify other risk factors for osteoporosis in these patients. A cross-sectional sample of patients attending the SLE Clinic at a teaching hospital was recruited. BMD was measured using dual-energy X-ray absorptiometry. Daily dietary calcium intake was assessed using a structured validated food frequency questionnaire, in which patients were asked to estimate their food intake based on their recent 2-month dietary habits. Sixty subjects were recruited with a mean age of 33.70+/-8.46 years. The median duration of CS use was 5.5 years (range 0.08-24). The median cumulative dose of steroids was 17.21 g (range 0.16-91.37). The median daily dietary calcium intake was 483 mg (range 78-2101). There was no significant correlation between calcium intake and BMD, even after correcting for CS use. There were also no correlations between BMD and the duration of SLE, cumulative CS use, duration of CS use, smoking, alcohol intake, and SLE disease activity index score. Twenty-eight (46.7%) patients had normal BMD, 28 (46.7%) had osteopenia, and four (6.6%) had osteoporosis. Duration of SLE significantly correlated with cumulative CS dosage. In conclusion, 6.7% of these Asian premenopausal SLE women had osteoporosis and only 46.7% had normal BMD. Daily dietary calcium intake did not correlate with BMD.

摘要

本研究的主要目的是确定接受皮质类固醇(CS)治疗的绝经前系统性红斑狼疮(SLE)女性的膳食钙摄入量与骨矿物质密度(BMD)之间的关系。次要目的是确定这些患者骨质疏松的其他风险因素。我们招募了一家教学医院SLE门诊的横断面样本患者。使用双能X线吸收法测量骨密度。使用经过验证的结构化食物频率问卷评估每日膳食钙摄入量,问卷要求患者根据其最近2个月的饮食习惯估算食物摄入量。共招募了60名受试者,平均年龄为33.70±8.46岁。CS使用的中位持续时间为5.5年(范围0.08 - 24年)。类固醇的中位累积剂量为17.21 g(范围0.16 - 91.37 g)。每日膳食钙摄入量的中位数为483 mg(范围78 - 2101 mg)。即使校正了CS使用情况,钙摄入量与BMD之间也无显著相关性。BMD与SLE病程、CS累积使用量、CS使用持续时间、吸烟、饮酒量及SLE疾病活动指数评分之间也均无相关性。28名(46.7%)患者骨密度正常,28名(46.7%)骨质减少,4名(6.6%)骨质疏松。SLE病程与CS累积剂量显著相关。总之,这些亚洲绝经前SLE女性中6.7%患有骨质疏松,仅46.7%骨密度正常。每日膳食钙摄入量与BMD无关。

相似文献

1
Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus.患有系统性红斑狼疮的绝经前女性的膳食钙与骨矿物质密度
Clin Rheumatol. 2007 Feb;26(2):182-5. doi: 10.1007/s10067-006-0258-6. Epub 2006 Mar 25.
2
Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.皮质类固醇对马来西亚绝经前系统性红斑狼疮患者骨矿物质密度的影响。
Lupus. 2009 Feb;18(2):178-81. doi: 10.1177/0961203308094995.
3
Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.系统性红斑狼疮患者骨量的决定因素:一项针对绝经前女性的横断面研究。
J Rheumatol. 1999 Jun;26(6):1280-4.
4
Decreased bone mineral density in premenopausal patients with systemic lupus erythematosus.绝经前系统性红斑狼疮患者的骨矿物质密度降低
Kaohsiung J Med Sci. 1996 Oct;12(10):567-72.
5
Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.患有系统性红斑狼疮、幼年皮肌炎和系统性血管炎的儿童及青少年的骨矿物质密度:与疾病持续时间、累积皮质类固醇剂量、钙摄入量及运动的关系
J Rheumatol. 2005 Apr;32(4):729-33.
6
Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.青少年系统性红斑狼疮患者低骨密度的患病率及病因
Arthritis Rheum. 2007 Jun;56(6):1966-73. doi: 10.1002/art.22691.
7
Bone mineral density in premenopausal women with systemic lupus erythematosus.患有系统性红斑狼疮的绝经前女性的骨矿物质密度
J Rheumatol. 2003 Nov;30(11):2365-8.
8
Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.绝经前系统性红斑狼疮女性骨矿物质密度变化的三年随访
J Rheumatol. 1999 Feb;26(2):310-7.
9
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.绝经前新发系统性红斑狼疮女性的骨损伤特征为骨改建脱耦联。
Lupus. 2021 Jun;30(7):1116-1123. doi: 10.1177/09612033211005067. Epub 2021 Apr 8.
10
Factors associated with low bone mineral density in female patients with systemic lupus erythematosus.系统性红斑狼疮女性患者骨矿物质密度低的相关因素。
J Rheumatol. 2001 Jan;28(1):102-8.

引用本文的文献

1
Association of Dietary Calcium Intake With Bone Health and Chronic Diseases: Two Prospective Cohort Studies in China.膳食钙摄入量与骨骼健康及慢性疾病的关联:中国两项前瞻性队列研究
Front Nutr. 2021 Dec 24;8:683918. doi: 10.3389/fnut.2021.683918. eCollection 2021.
2
Prevalence and Risk Factors of Reduced Bone Mineral Density in Systemic Lupus Erythematosus Patients: A Meta-Analysis.系统性红斑狼疮患者骨密度降低的患病率及危险因素:一项荟萃分析
Biomed Res Int. 2019 Feb 20;2019:3731648. doi: 10.1155/2019/3731648. eCollection 2019.
3
Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

本文引用的文献

1
Bone mineral density in premenopausal women with systemic lupus erythematosus.患有系统性红斑狼疮的绝经前女性的骨矿物质密度
J Rheumatol. 2003 Nov;30(11):2365-8.
2
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.皮质类固醇诱导的骨质疏松症的流行病学:一项荟萃分析。
Osteoporos Int. 2002 Oct;13(10):777-87. doi: 10.1007/s001980200108.
3
Dietary calcium intake in postmenopausal Malaysian women: comparison between the food frequency questionnaire and three-day food records.马来西亚绝经后女性的膳食钙摄入量:食物频率问卷与三日食物记录的比较
系统性红斑狼疮患者骨密度的 6 年随访研究。
Osteoporos Int. 2013 Jun;24(6):1827-33. doi: 10.1007/s00198-012-2157-9. Epub 2012 Oct 3.
4
Glucocorticoid-induced osteoporosis in rheumatic diseases.风湿性疾病中的糖皮质激素诱导性骨质疏松症。
Clinics (Sao Paulo). 2010;65(11):1197-205. doi: 10.1590/s1807-59322010001100024.
5
Bone health in systemic lupus erythematosus.系统性红斑狼疮中的骨骼健康
Curr Rheumatol Rep. 2009 Jul;11(3):177-84. doi: 10.1007/s11926-009-0024-2.
Asia Pac J Clin Nutr. 2002;11(2):142-6. doi: 10.1046/j.1440-6047.2002.00276.x.
4
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.糖皮质激素性骨质疏松症的预防和治疗建议:2001年更新版。美国风湿病学会糖皮质激素性骨质疏松症特别委员会
Arthritis Rheum. 2001 Jul;44(7):1496-503. doi: 10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5.
5
Effects of diary food supplements on bone mineral density in teenage girls.乳制品补充剂对少女骨密度的影响。
Eur J Nutr. 2000 Dec;39(6):256-62. doi: 10.1007/s003940070004.
6
Increasing weight-bearing physical activity and calcium intake for bone mass growth in children and adolescents: a review of intervention trials.增加负重体育活动和钙摄入量以促进儿童和青少年骨骼生长:干预试验综述
Prev Med. 2000 Dec;31(6):722-31. doi: 10.1006/pmed.2000.0758.
7
Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women.运动对绝经前后女性骨量影响的随机试验系统评价。
Calcif Tissue Int. 2000 Jul;67(1):10-8. doi: 10.1007/s00223001089.
8
Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine.绝经前女性系统性红斑狼疮患者骨密度的纵向分析:糖皮质激素治疗对腰椎的有害作用
Rheumatology (Oxford). 2000 Apr;39(4):389-92. doi: 10.1093/rheumatology/39.4.389.
9
Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.系统性红斑狼疮患者骨量的决定因素:一项针对绝经前女性的横断面研究。
J Rheumatol. 1999 Jun;26(6):1280-4.
10
Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data.系统性红斑狼疮女性的骨折发生率:与美国人群数据的比较。
Arthritis Rheum. 1999 May;42(5):882-90. doi: 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C.